Jefferies Downgrades HCP To Neutral

By: via Benzinga
Analysts at Jefferies downgraded HCP (NYSE: HCP) from Buy to Neutral. The price target for HCP has been lowered from $47.00 to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.